SMTL ID : 3bsc.2 (1 other biounit)

Crystal Structure of HCV NS5B Polymerase with a Novel Pyridazinone Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.65 Å

Oligo State

monomer

Ligands

1 x 2PD: 5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one(Non-covalent)

2PD.1: 17 residues within 4Å: Chain A: F.193, P.197, R.200, N.316, G.317, D.318, C.366, S.368, L.384, G.410, N.411, M.414, Y.415, Q.446, Y.448, G.449, S.556 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:P.197, A:Y.448 Hydrogen bonds: A:D.318, A:Y.415, A:Y.448, A:S.556 Water bridges: A:G.449, A:G.449, A:S.556 pi-Stacking: A:F.193, A:F.193, A:Y.448

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Zhou, Y. et al., Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: exploration of 7'-substitution of benzothiadiazine. Bioorg.Med.Chem.Lett. (2008)

Release Date

2008-12-23

Peptides

RNA-directed RNA polymerase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

RNA-directed RNA polymerase

Related Entries With Identical Sequence